The patient on methylphenidate (Ritalin) should be assessed for:
Signs of weight loss
Renal toxicity
Hypotension
Extreme euphoria and insomnia
The Correct Answer is A
A. Weight loss is a common side effect of methylphenidate (Ritalin) and should be monitored during treatment.
B. Methylphenidate is not typically associated with renal toxicity.
C. Methylphenidate can cause increases in blood pressure and heart rate, not hypotension.
D. Extreme euphoria and insomnia may indicate overstimulation or inappropriate dosing but are not typical side effects of methylphenidate.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Suspended release formulations typically have a slower onset of action compared to sublingual administration.
B. Transdermal patches provide a slow, continuous release of nitroglycerin and do not offer rapid onset.
C. Topical ointments have a slower onset of action compared to sublingual administration.
D. Sublingual administration of nitroglycerin provides the most rapid onset of action due to direct absorption through the oral mucosa.
Correct Answer is C
Explanation
A. Verapamil is a calcium channel blocker, not a beta blocker.
B. Captopril is an angiotensin-converting enzyme (ACE) inhibitor, not a beta blocker.
C. Atenolol is a beta blocker commonly used to treat hypertension, angina, and other cardiovascular conditions.
D. Clopidogrel is an antiplatelet medication used to prevent blood clots, not a beta blocker.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today